Amylin Submits Once-Weekly Byetta After Shedding 200 Sales Reps

Label with expanded language about thyroid cancer risk is expected.

Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

More from Archive

More from Pink Sheet